Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by MarketMoneyon Dec 14, 2020 11:33am
94 Views
Post# 32099775

RE:TRIPP is a failure

RE:TRIPP is a failure
Stockish12 wrote: When will people stop sugarcoating things and just accept this is a company with a great product but Tripp is a failure.

Just for those who do not know simple maths, we are at 0.08 pre-consolidation.

Think of it, even without the luck of covid testing that gave this company a boost, that product alone launching in Q1 should have this at over $1.50 at the minimum. Yet, with the addition of covid testing funds, you are still at 0.64? That is woeful.

This company will have the best product in the market but will still be the worst priced. Tripp is not CEO material. 

The financing company at 0.78 probably cannot wait to just break even.


Instead of belittle others, what can you do to improve things? It's easy to critizise but what can you do to get things betters? What's your ideas? What are you doing to get things better?

have a great day!

<< Previous
Bullboard Posts
Next >>